ROCKVILLE, Md.--(BUSINESS WIRE)--Feb. 10, 2012--
Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its
presentation at the 14th Annual BIO CEO & Investor Conference will be
webcast and may be accessed at www.hgsi.com.
A member of Human Genome Sciences’ senior management team will present a
corporate overview on Tuesday, February 14, 2012, at 11:30 AM Eastern
time. Investors interested in listening to the live webcast may want to
log on before the presentation begins to download any software required.
The archive of the presentation will be available for several days
following the event.
ABOUT HUMAN GENOME SCIENCES
Human Genome Sciences exists to place new therapies into the hands of
those battling serious disease.
For more information about HGS, please visit the Company’s web site at www.hgsi.com.
Health professionals and patients interested in clinical trials of HGS
products may inquire via e-mail to email@example.com
or by calling HGS at (240) 314-4430.
HGS and Human Genome Sciences are trademarks of Human Genome Sciences,
Inc. Other trademarks referenced are the property of their respective
Source: Human Genome Sciences, Inc.
Human Genome Sciences, Inc.
Director, Corporate Public Relations
Vice President, Corporate Communications
Claudine Prowse, Ph.D.
Director, Investor Relations